Abstract:Abstract Background Gastrointestinal stromal tumor (GIST) is a common tumor that originates from the alimentary system mesenchyme. Compared to typical gastrointestinal carcinomas, GISTs exhibit unique malignant behaviors. Bioinformatic tools and subsequent experiments were applied to investigate novel targets involved in GIST progression and imatinib resistance. Methods Differences in gene expression profiles between advanced and nonadvanced GISTs were comprehensively analyzed based on the Gene Expression Omnibus (GEO) dataset GSE136755. A protein–protein interaction (PPI) network was constructed to identify the potential target gene. Gene set enrichment analysis (GSEA) was used to elucidate relevant biological events related to the target gene based on the GSE47911 dataset. Subsequently, immunohistochemistry and Kaplan–Meier analysis were performed to validate the prognostic value of the target gene in GISTs. Overexpression of the target gene was conducted to analyze its function in the proliferation, apoptosis, and imatinib resistance of GIST/T1 cells. Results In the current study, a total of 606 differentially expressed genes (DEGs) were screened based on the GSE136755 dataset, and the upregulated DEGs in advanced GISTs were mainly involved in cell division through functional annotations. The intersecting hub gene, Aurora kinase A (AURKA), was identified by degree and bottleneck algorithms. GSEA revealed that AURKA was involved in cell cycle-related biological processes. Analysis of the Oncomine and GEPIA databases revealed a pattern of elevated AURKA expression in most human malignances. Clinical assays demonstrated that AURKA could be an independent prognostic factor for GISTs. Additionally, overexpression of AURKA was experimentally demonstrated to promote cell proliferation, inhibit cell apoptosis, and enhance imatinib resistance in GIST/T1 cells. Conclusions These findings indicated that overexpression of AURKA promoted GIST progression and enhanced imatinib resistance, implying that AURKA is a potential therapeutic target for GISTs.

IQGAP1 Interacts with Aurora-A and Enhances Its Stability and Its Role in Cancer.

Aurora-A Promotes the Establishment of Spindle Assembly Checkpoint by Priming the Haspin-Aurora-B Feedback Loop in Late G2 Phase

GASP1 enhances malignant phenotypes of breast cancer cells and decreases their response to paclitaxel by forming a vicious cycle with IGF1/IGF1R signaling pathway

RACK1 affects the progress of G2/M by regulating Aurora-A.

Aurora A Is Essential for Early Embryonic Development and Tumor Suppression

Aurora-A Interacts with Cyclin B1 and Enhances Its Stability.

Iqgap1 is Overexpressed in Hepatocellular Carcinoma and Promotes Cell Proliferation by Akt Activation

Overexpression and Biological Function of IQGAP3 in Human Pancreatic Cancer.

The interplay between IQGAP1 and small GTPases in cancer metastasis

The scaffolding protein IQGAP1 enhances EGFR signaling by promoting oligomerization and preventing degradation

Aurora-A Interacts With Ap-2 Alpha And Down Regulates Its Transcription Activity

Aurora kinase A (AURKA) promotes the progression and imatinib resistance of advanced gastrointestinal stromal tumors

IQGAP1 stimulates actin assembly through the N-WASP-Arp2/3 pathway

IQGAP1 silencing suppresses the malignant characteristics of laryngeal squamous cell carcinoma cells

Ubiquitination of the scaffold protein IQGAP1 diminishes its interaction with and activation of the Rho GTPase CDC42

IQGAP1 Promotes Pancreatic Cancer Progression and Epithelial-Mesenchymal Transition (EMT) Through Wnt/β-catenin Signaling.

Aurora-A interacts with AP-2α and down regulates its transcription activity.

Iqgap3 Promotes Egfr-Erk Signaling and the Growth and Metastasis of Lung Cancer Cells

Aurora-A kinase-inactive mutants disrupt the interaction with Ajuba and cause defects in mitotic spindle formation and G2/M phase arrest in HeLa cells.

E2F1 Transactivates IQGAP3 and Promotes Proliferation of Hepatocellular Carcinoma Cells Through IQGAP3-mediated PKC-alpha Activation.

The Role of Aurora-A in Human Cancers and Future Therapeutics.